Chronic Obstructive Pulmonary Disease Patient Preferences Survey
NCT ID: NCT02970422
Last Updated: 2020-12-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2016-11-30
2018-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267
Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00292552
Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort
NCT05762861
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622
Small Bioactive Molecules in Early COPD Diseases
NCT04950023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quartile 1 [Mild]
Patient Survey
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 2 [Moderate]
Patient Survey
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 3 [Severe]
Patient Survey
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 4 [Very Severe]
Patient Survey
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Survey
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English or French speaking
* Patient at one of the three participating sites with medical chart
Exclusion Criteria
* Unable to communicate in English or French
* Unable to provide informed consent
* No medical chart information at one of the three participating sites
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dennis Jensen, Ph.D.
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dennis Jensen, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
McGill University
Shane N Sweet, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montreal Chest Institute of the McGill University Health Center (MUHC)
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Exercise and Respiratory Physiology Laboratory (CERPL)
Theories and Interventions in Exercise and Health Psychology (TIE) Laboratory
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-203-MUHC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.